Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
University of Maryland, College Park, Maryland, USA.
Transfusion. 2020 Nov;60(11):2565-2580. doi: 10.1111/trf.16019. Epub 2020 Sep 13.
Intraoperative massive transfusion (MT) is common during liver transplantation (LT). A predictive model of MT has the potential to improve use of blood bank resources.
Development and validation cohorts were identified among deceased-donor LT recipients from 2010 to 2016. A multivariable model of MT generated from the development cohort was validated with the validation cohort and refined using both cohorts. The combined cohort also validated the previously reported McCluskey risk index (McRI). A simple modified risk index (ModRI) was then created from the combined cohort. Finally, a method to translate model predictions to a population-specific blood allocation strategy was described and demonstrated for the study population.
Of the 403 patients, 60 (29.6%) in the development and 51 (25.5%) in the validation cohort met the definition for MT. The ModRI, derived from variables incorporated into multivariable model, ranged from 0 to 5, where 1 point each was assigned for hemoglobin level of less than 10 g/dL, platelet count of less than 100 × 10 /dL, thromboelastography R interval of more than 6 minutes, simultaneous liver and kidney transplant and retransplantation, and a ModRI of more than 2 defined recipients at risk for MT. The multivariable model, McRI, and ModRI demonstrated good discrimination (c statistic [95% CI], 0.77 [0.70-0.84]; 0.69 [0.62-0.76]; and 0.72 [0.65-0.79], respectively, after correction for optimism). For blood allocation of 6 or 15 units of red blood cells (RBCs) based on risk of MT, the ModRI would prevent unnecessary crossmatching of 300 units of RBCs/100 transplants.
Risk indices of MT in LT can be effective for risk stratification and reducing unnecessary blood bank resource utilization.
肝移植(LT)过程中常发生术中大量输血(MT)。MT 预测模型有可能改善血库资源的利用。
从 2010 年至 2016 年,在已故供体 LT 受者中确定了发展队列和验证队列。从发展队列中生成的 MT 多变量模型在验证队列中进行了验证,并在两个队列中进行了改进。合并队列还验证了先前报道的 McCluskey 风险指数(McRI)。然后,从合并队列中创建了一个简单的改良风险指数(ModRI)。最后,描述并演示了一种将模型预测转化为特定人群血液分配策略的方法,并在研究人群中进行了演示。
在 403 名患者中,发展队列中有 60 名(29.6%)和验证队列中有 51 名(25.5%)符合 MT 定义。ModRI 源自纳入多变量模型的变量,范围从 0 到 5,其中血红蛋白水平<10g/dL、血小板计数<100×10/dL、血栓弹性图 R 间隔>6 分钟、同时进行肝和肾移植和再次移植,以及 ModRI>2 定义为 MT 风险患者,各赋值 1 分。多变量模型、McRI 和 ModRI 显示出良好的区分度(校正后 optimism 的 C 统计量[95%CI],分别为 0.77 [0.70-0.84];0.69 [0.62-0.76];0.72 [0.65-0.79])。对于基于 MT 风险分配 6 或 15 个单位的红细胞(RBC),ModRI 将避免 300 个单位 RBC/100 移植的不必要交叉配型。
LT 中 MT 的风险指数可有效用于风险分层和减少不必要的血库资源利用。